Jan Lennart von Hacht

Company: 3B Pharmaceuticals

Job title: Project & Alliance Manager

Seminars:

Bridging the Gap Between Preclinical Studies and Clinical Development – Fih Phase 0 Studies 4:30 pm

Exploring the Role of Phase 0 Studies: Understanding the significance of Phase 0 studies in the development of targeted radiopharmaceuticals (TRP) and their role as a crucial intermediate step between preclinical research and Phase 1/2 clinical trials Advantages and Challenges: Discussing the advantages and challenges associated with conducting Phase 0 studies, including their potential to…Read more

day: Conference Day 2